Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab

類似資料

• Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy
  著者:: Ogawara, Daiki, 等
  出版事項: (2017)
• Successful treatment with nivolumab for lung cancer with low expression of PD‐L1 and prominent tumor‐infiltrating B cells and immunoglobulin G
  著者:: Suyama, Takayuki, 等
  出版事項: (2018)
• Pitfalls in diagnosis with the use of circulating tumor‐derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M
  著者:: Ogawara, Daiki, 等
  出版事項: (2017)
• Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient
  著者:: Ogawara, Daiki, 等
  出版事項: (2017)
• Presence of few PD‐1‐expressing tumor‐infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non‐small cell lung cancer: An exploratory case series
  著者:: Ogawara, Daiki, 等
  出版事項: (2018)